High Levels of TRIM5α Are Associated with Xenophagy in HIV-1-Infected Long-Term Nonprogressors.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
14 05 2021
Historique:
received: 02 04 2021
revised: 07 05 2021
accepted: 13 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 26 10 2021
Statut: epublish

Résumé

Autophagy is a lysosomal-dependent degradative mechanism essential in maintaining cellular homeostasis, but it is also considered an ancient form of innate eukaryotic fighting against invading microorganisms. Mounting evidence has shown that HIV-1 is a critical target of autophagy that plays a role in HIV-1 replication and disease progression. In a special subset of HIV-1-infected patients that spontaneously and durably maintain extremely low viral replication, namely, long-term nonprogressors (LTNP), the resistance to HIV-1-induced pathogenesis is accompanied, in vivo, by a significant increase in the autophagic activity in peripheral blood mononuclear cells. Recently, a new player in the battle of autophagy against HIV-1 has been identified, namely, tripartite motif protein 5α (TRIM5α). In vitro data demonstrated that TRIM5α directly recognizes HIV-1 and targets it for autophagic destruction, thus protecting cells against HIV-1 infection. In this paper, we analyzed the involvement of this factor in the control of HIV-1 infection through autophagy, in vivo, in LTNP. The results obtained showed significantly higher levels of TRIM5α expression in cells from LTNP with respect to HIV-1-infected normal progressor patients. Interestingly, the colocalization of TRIM5α and HIV-1 proteins in autophagic vacuoles in LTNP cells suggested the participation of TRIM5α in the autophagy containment of HIV-1 in LTNP. Altogether, our results point to a protective role of TRIM5α in the successful control of the chronic viral infection in HIV-1-controllers through the autophagy mechanism. In our opinion, these findings could be relevant in fighting against HIV-1 disease, because autophagy inducers might be employed in combination with antiretroviral drugs.

Identifiants

pubmed: 34069225
pii: cells10051207
doi: 10.3390/cells10051207
pmc: PMC8156091
pii:
doi:

Substances chimiques

Antiviral Restriction Factors 0
Tripartite Motif Proteins 0
TRIM5 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Ministry of Health
ID : E56C18000460002
Organisme : Italian Ministry of Health
ID : Ricerca Corrente and Finalizzata
Organisme : Italian Ministry of University and Research
ID : PRIN 2015 20152CB22L

Références

Autophagy. 2017 May 4;13(5):989-990
pubmed: 26983397
PLoS Pathog. 2018 Feb 1;14(2):e1006787
pubmed: 29389992
Am J Pathol. 2005 Sep;167(3):695-704
pubmed: 16127150
Nat Rev Immunol. 2013 Oct;13(10):722-37
pubmed: 24064518
PLoS Pathog. 2020 Oct 14;16(10):e1009017
pubmed: 33052966
J Virol. 1999 Oct;73(10):8824-30
pubmed: 10482638
Nature. 2004 Feb 26;427(6977):848-53
pubmed: 14985764
J Cell Sci. 2015 Mar 15;128(6):1166-79
pubmed: 25616897
PLoS One. 2009 Jun 03;4(6):e5787
pubmed: 19492063
Virology. 2006 Aug 1;351(2):404-19
pubmed: 16650449
Science. 2013 May 10;340(6133):697-701
pubmed: 23661751
Blood. 2010 Dec 16;116(25):5571-9
pubmed: 20837780
Autophagy. 2008 Jan;4(1):107-9
pubmed: 18000394
Retrovirology. 2013 Oct 16;10:106
pubmed: 24131498
J Biol Chem. 2018 Nov 23;293(47):18378-18386
pubmed: 30282803
Nat Microbiol. 2019 Jun;4(6):933-940
pubmed: 30886358
J Virol. 2010 Jun;84(12):5997-6006
pubmed: 20357094
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5514-9
pubmed: 16540544
Autophagy. 2014;10(12):2387-8
pubmed: 25587751
Immunity. 2013 Aug 22;39(2):211-27
pubmed: 23973220
Viruses. 2017 Sep 23;9(10):
pubmed: 28946621
Immunol Cell Biol. 2015 Jan;93(1):11-7
pubmed: 25385065
PLoS Pathog. 2008 May 23;4(5):e1000074
pubmed: 18497858
Autophagy. 2021 Feb 16;:1-15
pubmed: 33535890
J Intern Med. 2017 May;281(5):422-432
pubmed: 28139864
Dev Cell. 2014 Aug 25;30(4):394-409
pubmed: 25127057
Nat Rev Microbiol. 2018 Jun;16(6):341-354
pubmed: 29556036
J Biol Chem. 2011 May 27;286(21):18890-902
pubmed: 21454634
Nat Commun. 2020 Mar 11;11(1):1307
pubmed: 32161265
Nature. 2016 Dec 15;540(7633):448-452
pubmed: 27919079
Gynecol Oncol. 2009 Mar;112(3):623-30
pubmed: 19147209
Autophagy. 2021 Jan;17(1):1-382
pubmed: 33634751
Curr Biol. 2005 Jan 11;15(1):73-8
pubmed: 15649369
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29702-29711
pubmed: 33154161
J Clin Invest. 2015 Jan;125(1):75-84
pubmed: 25654553
Autophagy. 2014 Jul;10(7):1167-78
pubmed: 24813622
AIDS. 2021 May 1;35(6):899-910
pubmed: 33821820
Viruses. 2017 Jul 06;9(7):
pubmed: 28684681
Semin Immunol. 2021 Feb 26;:101472
pubmed: 33648815

Auteurs

Fabiola Ciccosanti (F)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Marco Corazzari (M)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
Center for Translational Research on Autoimmune and Allergic Disease, School of Medicine, University of Piemonte Orientale, 28100 Novara, Italy.

Rita Casetti (R)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Alessandra Amendola (A)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Diletta Collalto (D)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Giulia Refolo (G)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Alessandra Vergori (A)

Clinical Department, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Chiara Taibi (C)

Clinical Department, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Gianpiero D'Offizi (G)

Clinical Department, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Andrea Antinori (A)

Clinical Department, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Chiara Agrati (C)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Gian Maria Fimia (GM)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.

Giuseppe Ippolito (G)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Mauro Piacentini (M)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Roberta Nardacci (R)

Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH